Product Images Teglutik
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Teglutik NDC 70726-0304 by Edw Pharma, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of the Kaplan-Meier Survival Curves for Riluzole and Placebo. The survival probability at various time points is presented, along with the number of participants in each group (77 for Riluzole and 78 for Placebo). No additional context or information is available.*
This is a description of a graph showing the Kaplan-Meier survival curves for a placebo group and a group taking Riluzole 50mg twice a day. The survival probability is being analyzed. No further information is available.*
This is a drug called Tiglutik with the active ingredient Riluzole. It is an oral suspension containing 50mg of Riluzole per 10mL (5mg/ml) supplied with syringes for oral administration. The product comes in two bottles, each containing 300mL, and includes two 10mL oral syringes and two syringe bottle adapters. The liquid suspension is slightly brown opaque and should be shaken gently before use. It is important to read the enclosed Prescribing Information before use. The total amount of the product is 600mL, which comes in two bottles not to be dispensed separately. Proper disposal is recommended, and it should be kept out of reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.